3rd Pharma Meets AI Conference on 19 and 20 April 2027 in Barcelona, hosted by UBIQ Events. Director-level executives from leading pharmaceutical companies share their expertise and real-world case studies on how artificial intelligence is...
We are excited to announce that the World Congress of Bronchology and Interventional Pulmonology 2026 will be hosted by the Thoracic Society of Australia and New Zealand in the vibrant city of Melbourne, Australia. We are excited to announce that...
3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress 2026), taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the...
2026 / The International Exhibition on Analytical and Laboratory Equipment in Vietnam - VietLab Expo 2024 from November 21 - 23, 2026 at Saigon Exhibition & Convention Center (SECC). Vietnam Medical Devices Association highly appreciates Vietnam...
A drug nearing patent expiration may seem like relief from high prices, but lower-cost competition can still take years to reach the market. Employers cannot control when a patent expires, a lawsuit is resolved, or when a biosimilar reaches the...
Seawolf Therapeutics announced its emergence from stealth, having raised $100 million to transform patient outcomes through the use of its proprietary DNA delivery platform. Founding investor Versant Ventures led the seed round, followed by the...
poster presentation at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 12–15, 2026, in New Orleans, Louisiana. The research, described in Abstract #2375, supports the potential of Eureka...
that its Board of Directors is adding Eicke Latz, MD PhD to serve on its board of directors, effective as of January 1, 2027. Dr. Latz is an internationally recognized medical institute director, physician-scientist, successful biopharma...
CS Analytical (CSA), doing business as Raw Material Analytical (RMA), a cGMP laboratory dedicated to advancing product quality and patient safety, today announced that it is set to offer analytical testing for sunscreen ingredients used in...
Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will take place on November 13–14, 2026. 6th International Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious...
of VectorY’s lead program, VTx-002, through key clinical milestones, including the final readout of the PIONEER-ALS® Phase 1/2 clinical study. The global study is evaluating VTx-002 in people living with amyotrophic lateral sclerosis (ALS). In...
ProBio, a global contract research, development, and manufacturing organization announced that it has entered into an exclusive global licensing agreement with AbTis Co., Ltd., a South Korean biotechnology company and subsidiary of Dong-A ST,...
Waters Corporation announced that the BD OneFlow LST Test and BD OneFlow B-CLPD T1 Test have received U.S. Food and Drug Administration (FDA) 510(k) clearance. This clearance enables commercialization in the U.S. and provides pathologists and...
with antiplatelet therapy to reduce the risk of stroke in adults with recent non-cardioembolic ischemic stroke (NIHSS ≤15) or high-risk transient ischemic attack (TIA). Reducing the risk of a stroke after an initial event is often referred to as...
eligibility for filling a prescription of YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%. To access the YUVEZZI telehealth program, visit orderYUVEZZI.com or call 800-204-3511 for more information. The YUVEZZI program...
announced Week 24 data for BIMZELX® (bimekizumab-bkzx) from BE BOLD, building on the study's previously reported Week 16 results, which demonstrated statistically significant superiority in ACR50 joint outcomes versus risankizumab at Week 16 in...
and nephrology with stem cell therapy and hematology oncology. Founded in 2022, Avanzanite now employs more than 110 people across Europe; the company serves more than 400 patients. About Zemcelpro ® Zemcelpro is an allogeneic hematopoietic stem...
the primary endpoint, with 58% of patients achieving an American College of Rheumatology 20 (ACR20) response compared with 41% receiving placebo at Week 16.2 Safety findings were consistent with the established safety profile of ICOTYDE, with no...
an FDA-approved Lilly medicine shipped directly to their home, all in one seamless experience. Self-pay pricing starts at $149 per month for Foundayo and $299 per month for Zepbound. “At Lilly, we are always looking for new ways to help more people...
Roche announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the cobas® eplex respiratory pathogen panel 3 (RP3). Designed for the automated cobas® eplex system, this flexible syndromic test offers up to five customizable panel...